Cargando…
PB2307: PHARMACOKINETICS, EFFICACY AND SAFETY OF SUBCUTANEOUS VERSUS INTRAVENOUS RITUXIMAB COMBINED WITH CHOP IN CHINESE PATIENTS WITH UNTREATED CD20-POSITIVE DIFFUSE LARGE B CELL LYMPHOMA: A RANDOMIZED TRIAL
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429010/ http://dx.doi.org/10.1097/01.HS9.0000975952.54634.fd |
| _version_ | 1785090608633741312 |
|---|---|
| author | Gao, Yan Zhang, Liling Gao, Sujun Yang, Yu Zhang, Qing-Yuan Zhang, Huilai He, Pengcheng LI, Fei Jing, Hongmei Grange, Susan Bu, Lilian Wang, Qianming Wang, Yanjie Huang, Huiqiang |
| author_facet | Gao, Yan Zhang, Liling Gao, Sujun Yang, Yu Zhang, Qing-Yuan Zhang, Huilai He, Pengcheng LI, Fei Jing, Hongmei Grange, Susan Bu, Lilian Wang, Qianming Wang, Yanjie Huang, Huiqiang |
| author_sort | Gao, Yan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429010 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104290102023-08-17 PB2307: PHARMACOKINETICS, EFFICACY AND SAFETY OF SUBCUTANEOUS VERSUS INTRAVENOUS RITUXIMAB COMBINED WITH CHOP IN CHINESE PATIENTS WITH UNTREATED CD20-POSITIVE DIFFUSE LARGE B CELL LYMPHOMA: A RANDOMIZED TRIAL Gao, Yan Zhang, Liling Gao, Sujun Yang, Yu Zhang, Qing-Yuan Zhang, Huilai He, Pengcheng LI, Fei Jing, Hongmei Grange, Susan Bu, Lilian Wang, Qianming Wang, Yanjie Huang, Huiqiang Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429010/ http://dx.doi.org/10.1097/01.HS9.0000975952.54634.fd Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Gao, Yan Zhang, Liling Gao, Sujun Yang, Yu Zhang, Qing-Yuan Zhang, Huilai He, Pengcheng LI, Fei Jing, Hongmei Grange, Susan Bu, Lilian Wang, Qianming Wang, Yanjie Huang, Huiqiang PB2307: PHARMACOKINETICS, EFFICACY AND SAFETY OF SUBCUTANEOUS VERSUS INTRAVENOUS RITUXIMAB COMBINED WITH CHOP IN CHINESE PATIENTS WITH UNTREATED CD20-POSITIVE DIFFUSE LARGE B CELL LYMPHOMA: A RANDOMIZED TRIAL |
| title | PB2307: PHARMACOKINETICS, EFFICACY AND SAFETY OF SUBCUTANEOUS VERSUS INTRAVENOUS RITUXIMAB COMBINED WITH CHOP IN CHINESE PATIENTS WITH UNTREATED CD20-POSITIVE DIFFUSE LARGE B CELL LYMPHOMA: A RANDOMIZED TRIAL |
| title_full | PB2307: PHARMACOKINETICS, EFFICACY AND SAFETY OF SUBCUTANEOUS VERSUS INTRAVENOUS RITUXIMAB COMBINED WITH CHOP IN CHINESE PATIENTS WITH UNTREATED CD20-POSITIVE DIFFUSE LARGE B CELL LYMPHOMA: A RANDOMIZED TRIAL |
| title_fullStr | PB2307: PHARMACOKINETICS, EFFICACY AND SAFETY OF SUBCUTANEOUS VERSUS INTRAVENOUS RITUXIMAB COMBINED WITH CHOP IN CHINESE PATIENTS WITH UNTREATED CD20-POSITIVE DIFFUSE LARGE B CELL LYMPHOMA: A RANDOMIZED TRIAL |
| title_full_unstemmed | PB2307: PHARMACOKINETICS, EFFICACY AND SAFETY OF SUBCUTANEOUS VERSUS INTRAVENOUS RITUXIMAB COMBINED WITH CHOP IN CHINESE PATIENTS WITH UNTREATED CD20-POSITIVE DIFFUSE LARGE B CELL LYMPHOMA: A RANDOMIZED TRIAL |
| title_short | PB2307: PHARMACOKINETICS, EFFICACY AND SAFETY OF SUBCUTANEOUS VERSUS INTRAVENOUS RITUXIMAB COMBINED WITH CHOP IN CHINESE PATIENTS WITH UNTREATED CD20-POSITIVE DIFFUSE LARGE B CELL LYMPHOMA: A RANDOMIZED TRIAL |
| title_sort | pb2307: pharmacokinetics, efficacy and safety of subcutaneous versus intravenous rituximab combined with chop in chinese patients with untreated cd20-positive diffuse large b cell lymphoma: a randomized trial |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429010/ http://dx.doi.org/10.1097/01.HS9.0000975952.54634.fd |
| work_keys_str_mv | AT gaoyan pb2307pharmacokineticsefficacyandsafetyofsubcutaneousversusintravenousrituximabcombinedwithchopinchinesepatientswithuntreatedcd20positivediffuselargebcelllymphomaarandomizedtrial AT zhangliling pb2307pharmacokineticsefficacyandsafetyofsubcutaneousversusintravenousrituximabcombinedwithchopinchinesepatientswithuntreatedcd20positivediffuselargebcelllymphomaarandomizedtrial AT gaosujun pb2307pharmacokineticsefficacyandsafetyofsubcutaneousversusintravenousrituximabcombinedwithchopinchinesepatientswithuntreatedcd20positivediffuselargebcelllymphomaarandomizedtrial AT yangyu pb2307pharmacokineticsefficacyandsafetyofsubcutaneousversusintravenousrituximabcombinedwithchopinchinesepatientswithuntreatedcd20positivediffuselargebcelllymphomaarandomizedtrial AT zhangqingyuan pb2307pharmacokineticsefficacyandsafetyofsubcutaneousversusintravenousrituximabcombinedwithchopinchinesepatientswithuntreatedcd20positivediffuselargebcelllymphomaarandomizedtrial AT zhanghuilai pb2307pharmacokineticsefficacyandsafetyofsubcutaneousversusintravenousrituximabcombinedwithchopinchinesepatientswithuntreatedcd20positivediffuselargebcelllymphomaarandomizedtrial AT hepengcheng pb2307pharmacokineticsefficacyandsafetyofsubcutaneousversusintravenousrituximabcombinedwithchopinchinesepatientswithuntreatedcd20positivediffuselargebcelllymphomaarandomizedtrial AT lifei pb2307pharmacokineticsefficacyandsafetyofsubcutaneousversusintravenousrituximabcombinedwithchopinchinesepatientswithuntreatedcd20positivediffuselargebcelllymphomaarandomizedtrial AT jinghongmei pb2307pharmacokineticsefficacyandsafetyofsubcutaneousversusintravenousrituximabcombinedwithchopinchinesepatientswithuntreatedcd20positivediffuselargebcelllymphomaarandomizedtrial AT grangesusan pb2307pharmacokineticsefficacyandsafetyofsubcutaneousversusintravenousrituximabcombinedwithchopinchinesepatientswithuntreatedcd20positivediffuselargebcelllymphomaarandomizedtrial AT bulilian pb2307pharmacokineticsefficacyandsafetyofsubcutaneousversusintravenousrituximabcombinedwithchopinchinesepatientswithuntreatedcd20positivediffuselargebcelllymphomaarandomizedtrial AT wangqianming pb2307pharmacokineticsefficacyandsafetyofsubcutaneousversusintravenousrituximabcombinedwithchopinchinesepatientswithuntreatedcd20positivediffuselargebcelllymphomaarandomizedtrial AT wangyanjie pb2307pharmacokineticsefficacyandsafetyofsubcutaneousversusintravenousrituximabcombinedwithchopinchinesepatientswithuntreatedcd20positivediffuselargebcelllymphomaarandomizedtrial AT huanghuiqiang pb2307pharmacokineticsefficacyandsafetyofsubcutaneousversusintravenousrituximabcombinedwithchopinchinesepatientswithuntreatedcd20positivediffuselargebcelllymphomaarandomizedtrial |